Latest on Drug Hunter
-
Recent Highlights in Covalent Drug Discovery
In Wednesday’s Flash Talk webinar, we covered recent highlights in covalent drug discovery, with lots of great questions from…
1 min read
Top Premium Articles
-
Merck’s Oral PCSK9 Inhibitor and Nurix’s BTK Degrader Among ACS First Disclosures
12 mins read •
6 months ago
View All Premium Articles >
Why Did Bristol Myers Squibb (BMS) Pay $4.1 Billion for Turning Point Therapeutics?
8 mins read •
10 months ago
Molecule Case Studies
Resources
